Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E R Ford

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Clinical Colorectal Cancer|March 18, 2004
Phase III study of mitomycin-C with protracted venous infusion or circadian-timed infusion of 5-fluorouracil in advanced colorectal carcinomaTimothy J Price, Paul J Ross, Tamas Hickish, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Thymidylate synthase expression in advanced colorectal cancer predicts for response to raltitrexedDavid C Farrugia, Hugo E R Ford, David Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2008
Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II studyLucio Crinò, Federico Cappuzzo, Petr Zatloukal, et al.
The Hospital|May 30, 2018
The Queen's Hospital for ChildrenJ E Watts-Ditchfield, C E Fox, T E Young, et al.
The Lancet. Oncology|December 17, 2013
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trialHugo E R Ford, Andrea Marshall, John A Bridgewater, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Clinical Colorectal Cancer|March 18, 2004
Phase III study of mitomycin-C with protracted venous infusion or circadian-timed infusion of 5-fluorouracil in advanced colorectal carcinomaTimothy J Price, Paul J Ross, Tamas Hickish, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Thymidylate synthase expression in advanced colorectal cancer predicts for response to raltitrexedDavid C Farrugia, Hugo E R Ford, David Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2008
Gefitinib versus vinorelbine in chemotherapy-naive elderly patients with advanced non-small-cell lung cancer (INVITE): a randomized, phase II studyLucio Crinò, Federico Cappuzzo, Petr Zatloukal, et al.
The Hospital|May 30, 2018
The Queen's Hospital for ChildrenJ E Watts-Ditchfield, C E Fox, T E Young, et al.
The Lancet. Oncology|December 17, 2013
Docetaxel versus active symptom control for refractory oesophagogastric adenocarcinoma (COUGAR-02): an open-label, phase 3 randomised controlled trialHugo E R Ford, Andrea Marshall, John A Bridgewater, et al.
Pageof 2